These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Expression of phosphodiesterase 5 in maternal and fetal sheep. Coppage KH; Sun X; Baker RS; Clark KE Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1005-10. PubMed ID: 16157102 [TBL] [Abstract][Full Text] [Related]
9. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP. Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347 [TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5. Schankin CJ; Kruse LS; Reinisch VM; Jungmann S; Kristensen JC; Grau S; Ferrari U; Sinicina I; Goldbrunner R; Straube A; Kruuse C Headache; 2010 Mar; 50(3):431-41. PubMed ID: 19751368 [TBL] [Abstract][Full Text] [Related]
11. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation. Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular implications in the use of PDE5 inhibitor therapy. Maurice DH Int J Impot Res; 2004 Jun; 16 Suppl 1():S20-3. PubMed ID: 15224131 [TBL] [Abstract][Full Text] [Related]
13. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. Mancina R; Filippi S; Marini M; Morelli A; Vignozzi L; Salonia A; Montorsi F; Mondaini N; Vannelli GB; Donati S; Lotti F; Forti G; Maggi M Mol Hum Reprod; 2005 Feb; 11(2):107-15. PubMed ID: 15640438 [TBL] [Abstract][Full Text] [Related]
14. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling. Mullershausen F; Friebe A; Feil R; Thompson WJ; Hofmann F; Koesling D J Cell Biol; 2003 Mar; 160(5):719-27. PubMed ID: 12604588 [TBL] [Abstract][Full Text] [Related]
15. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord. de Vente J; Markerink-van Ittersum M; Vles JS J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445 [TBL] [Abstract][Full Text] [Related]
16. Allosteric activation of cGMP-specific, cGMP-binding phosphodiesterase (PDE5) by cGMP. Okada D; Asakawa S Biochemistry; 2002 Jul; 41(30):9672-9. PubMed ID: 12135389 [TBL] [Abstract][Full Text] [Related]
17. mRNA expression patterns of the cGMP-hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain. Van Staveren WC; Steinbusch HW; Markerink-Van Ittersum M; Repaske DR; Goy MF; Kotera J; Omori K; Beavo JA; De Vente J J Comp Neurol; 2003 Dec; 467(4):566-80. PubMed ID: 14624489 [TBL] [Abstract][Full Text] [Related]
18. Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells. Cawley SM; Sawyer CL; Brunelle KF; van der Vliet A; Dostmann WR Cell Signal; 2007 May; 19(5):1023-33. PubMed ID: 17207606 [TBL] [Abstract][Full Text] [Related]